StopAfib.org interviews Dr. Kenneth Ellenbogen of Virginia Commonwealth University. In this video, Dr. Ellenbogen talked about some of the exciting things for afib patients being presented at the 2010 American Heart Association Scientific Sessions. He discussed the presentation of the ROCKET AF clinical trial, which could provide a second new alternative to warfarin for afib stroke prevention, and how these alternatives could benefit patients. In addition, he discussed the results of trials regarding the efficacy of Lovaza (prescription fish oil) in the prevention of atrial fibrillation. Dr. Ellenbogen, a cardiologist and electrophysiologist, is the Chairman of the Division of Cardiology at the Pauley Heart Center, of the Virginia Commonwealth University Medical Center. Find more details on the interview, and more on Dr. Ellenbogen, at: www.stopafib.org
Keywords: atrial fibrillation, Kenneth Ellenbogen, afib, ROCKET AF, Lovaza, Dabigatran, Pradaxa, Warfarin, Lovenox
No comments:
Post a Comment